Shelia M. Violette

Insider Reports History

Entity
Individual
Location
Q32 Bio Inc., 830 Winter Street, Waltham, MA
Signature
/s/ Eric Bell, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Shelia M. Violette:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Homology Medicines, Inc. Chief Scientific Officer Stock Option (Right to Buy) 56.4K $757K $13.42 Mar 25, 2024 Direct
Homology Medicines, Inc. Chief Scientific Officer Common Stock 36.3K $20.7K $0.57 Mar 25, 2024 By Violette Holdings LLC

Insider Reports Filed by Shelia M. Violette

Symbol Company Period Transactions Value $ Form Type Date Filed Role
QTTB Homology Medicines, Inc. Mar 25, 2024 1 $0 4 Mar 27, 2024 Chief Scientific Officer
QTTB Homology Medicines, Inc. Mar 25, 2024 0 $0 3 Mar 27, 2024 Chief Scientific Officer